• Search
  • Helpdesk
  • Sales contact

Neuroscience

Turning neuroscience trial complexity into meaningful clinical evidence with eCOA

Neuroscience clinical trials face distinctive measurement challenges. Symptoms are often subjective, multidimensional, and variable across patients, raters, cultures, and study visits. Cognitive impairment can affect participants' ability to accurately recall...

Turning endpoint noise into reliable CNS trial data

Go back CNS Most CNS trials don't fail because the therapy doesn't work. They fail because assessment variability buries the...

Better Raters, Smarter eCOA, Stronger Data

Go back ● Replay Tackling variability in CNS clinical trials: Enhancing data reliability in neuroscience studies through structured rater training...

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical Officer at Kayentis

Endpoint reliability is a critical factor in the success of clinical trials, particularly those relying on clinician‑reported outcomes. Estelle Haenel,...

Kayentis and RWS join forces to improve data confidence in neuroscience clinical trials

Combining best-in-class electronic Clinical Outcome Assessment (eCOA) technology with expert rater training to reduce variability and strengthen clinical outcomes data...